Navigation Links
Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
Date:9/11/2007

ANA598 demonstrates favorable preclinical antiviral, metabolic,

pharmacokinetic and preliminary toxicologic properties

SAN DIEGO, Sept. 11 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS) presented preclinical data today on ANA598, a non-nucleoside inhibitor of the HCV NS5B polymerase, during a poster session at the 14th International Symposium on Hepatitis C Virus and Related Viruses.

The report characterized the favorable antiviral, metabolic, pharmacokinetic and preliminary toxicologic properties that supported the decision announced in June to progress ANA598 to IND enabling studies and subsequent clinical evaluation expected to commence in the first half of 2008. ANA598 is a potent, low-nanomolar inhibitor of HCV genotype 1a and 1b replicons and has exhibited good metabolic stability properties in in vitro preclinical studies. It also does not significantly inhibit or induce cytochrome enzymes, indicating that the compound has a low likelihood of producing clinical drug-drug interactions. ANA598 was well tolerated in 14-day dose range finding (DRF) animal toxicology studies at all doses tested (1 to 1000mg/kg). In in vivo preclinical studies designed to be predictive of potential human doses, trough plasma concentrations of ANA598 24 hours post dosing exceeded the EC95 for HCV genotype 1a and 1b replicon inhibition at doses corresponding to estimated human doses. The EC95 is the concentration required to suppress hepatitis C viral RNA levels by 95% in the replicon assay.

"We are pleased with the ANA598 plasma exposures we have observed in animal studies at doses that were well tolerated for 14 days," said Steve Worland, Ph.D., President and Chief Executive Of
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
2. Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor Activity of Natural Killer Cells
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...Newswire-USNewswire/--FebeDurango-Rueda,52,aColomb...tinginaschemetodefraudtheExport-ImportBankoftheUni...ssistantAttorneyGeneraloftheCriminalDivisionLannyA...ftheEx-ImBank,OfficeoftheInspectorGeneral. ,, D...S.DistrictCourtinWashingtontoaone-countcriminalinf...
(Date:11/23/2009)...PRNewswire-FirstCall/--Immucor,Inc.(Nasdaq: BLUD )...ntsystemstothebloodtransfusionindustry,todayannoun...tAnnualHealthCareConferenceinNewYork,NYwillbeavail...,spresentationisscheduledforTuesday,December1,2009...lbeavailablethroughthe"AboutUs--InvestorInformatio...
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--Amgen(Nasdaq: AMGN )...rallPipelineandforBestNewDrugforNplate®(romip...erallPipelineawardwaspresentedtoAmgenbyScripinreco...ofthecompany,spipeline,aswellasitsmixofcandidatesa...spipelineisnotableforitsfocusonunmetclinicalneed. ...
Breaking Medicine Technology:Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 1First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 2First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 3Small businesses would see lower costs more comprehensive coverage from health reform 56501 1Small businesses would see lower costs more comprehensive coverage from health reform 56501 2Small businesses would see lower costs more comprehensive coverage from health reform 56501 3Sinapis Pharma Announces Frederick Frank as Consultant 56499 1Sinapis Pharma Announces Frederick Frank as Consultant 56499 2
(Date:11/23/2009)...3, 2009) -- A first-of-its-kind consensus statemen... the Annals of Surgery . The report illustrates t...onference -- Diabetes Surgery Summit (DSS) -- wher...c and medical experts agreed on a set of evidence-... guide the use and study of gastrointestinal surge...
(Date:11/23/2009)...y, first woman to head the agency, said lives coul...Day News) -- The fallout from last week,s controve... routine mammogram testing for breast cancer conti...itutes of Health advising women to ignore the guid...em, because unequivocally this will increase the n...
(Date:11/23/2009)...ipswithMinorityBanksin Washington D.C. , New...mbia , S.C. IntendedtoSpurEconomicGrowthandRevi...ewswire/--DaVita,thenation,sleadingproviderofdialy...nitiativedesignedtocreatejobsandspurrevitalization...tsinleadingcommunityandminority-ownedbanks.DaVitah...
(Date:11/23/2009)...,Nov.23/PRNewswire-USNewswire/-- The AmericanLegi...dividualmembershipassociationofstatelegislators,co...tt forpre-filinga constitutionalamendment toprotec...ces.SouthCarolinanowbecomesthe24thstatewherelegisl...eledafterALEC,s FreedomofChoiceinHealthCareAct . ,...
(Date:11/23/2009)...v.23/PRNewswire/--Howistheeconomyaffectingpeople,s...hiWellnessonWellness&theEconomy,theeconomyisma...healthylifestyleofexerciseanddiettoonethatismorein..., Thesurvey,smostdramaticfindingwasthechangeinco...itionalfocusonhealthandwellbeingtotoday,smorerelev...
Breaking Medicine News(10 mins):Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:South Carolina Now 24th State to Defend Health Care Choice 2Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3
...al Lifeline for Americans Struggling With Serious ...Insurance Company of America (Guardian) supports N...ilies, business owners, benefits decision makers a...ional Stroke Association, stroke is the number one...
...es new "E" tool for detecting melanoma , , SCHAU...ch or backyard barbeques is a great way to honor t...ican Academy of Dermatology (Academy) hopes more f...ally melanoma (the deadliest form of skin canc...
...m Noblis Health Innovation, a leading non-profit a...e context of the current economic crisis, nearly a...affiliation than a year ago. Conducted in April 2... leading health care executives who have agreed to...
...ldiers, get to the site of infection or injury? T...of the blood vessel gripping it tightly to avoid ...searching for temporary ,road signs, made of speci...ished in the journal Immunity , Prof. Ronen Alon ...
...e to delay in treatment for women, signal need to ...OR, Mich., May 4 The traditional stroke symptoms ...ess or weakness on one side of the body, trouble t...Lisabeth, Ph.D., MPH, researcher in the department...
...tago,s Inventory of Infringing Products - , , ,... Company and its parent company Instrumentation La...s First Level Civil Court determined that Diagnost...ating advertisements. As a result, the Court ruled...
Other Medicine News:Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 2Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 3Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 4Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 2Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 3Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 4Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 5Health News:Noblis Insights Panel Finds Growing Interest in Hospital Affiliation as a Strategic Response to Challenging Market Conditions 2Health News:Noblis Insights Panel Finds Growing Interest in Hospital Affiliation as a Strategic Response to Challenging Market Conditions 3Health News:Weizmann Institute scientists show white blood cells move like millipedes 2Health News:Women More Likely to Experience Non-Traditional Stroke Symptoms 2Health News:Women More Likely to Experience Non-Traditional Stroke Symptoms 3Health News:Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics 2Health News:Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics 3
Whistle-tip Ureteral Catheters (Left Ureter)
Whistle-tip
40 Angled Tip Ureteral Catheter Set
20 Angled Tip Ureteral Catheter Set
Medicine Products: